Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01339520 · ClinicalTrials.gov registry record · NA

Diabetes Scorecard Educational Intervention Study

A NA study, sponsored by George Washington University.

Completed
Registry status
NA
Development phase
104
Enrollment target

NCT01339520: Completed NA study, sponsored by George Washington University.

NCT01339520 is a NA study that has completed, run by George Washington University. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01339520, a NA study, has completed, sponsored by George Washington University.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target

Study Summary

The purpose of this study is to see if the use of a diabetic scorecard during clinic visits can improve glycemic control, blood pressure control, LDL-cholesterol, aspirin usage, and amount of exercise in adults over age 40 with uncontrolled Type II diabetes.

Primary Outcome

The total score was calculated by points assigned to variables (systolic blood pressure, diastolic blood pressure, HbA1c, aspirin usage and daily exercise). The maximal score of 100 corresponds to all variables at target. Fewer points were assigned to higher blood pressure, worse HbA1c levels, less exercise, etc.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Scorecard

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2008-11
Est. Completion 2010-05
Phase NA
George Washington University

133 total trials

What the finished NCT01339520 record still lists

NCT01339520 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT01339520 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01339520 about?

NCT01339520 is a clinical study titled "Diabetes Scorecard Educational Intervention Study". The purpose of this study is to see if the use of a diabetic scorecard during clinic visits can improve glycemic control, blood pressure control, LDL-cholesterol, aspirin usage, and amount of exercise in adults over age 40 with uncontrolled Type II diabetes.

What is the current status of trial NCT01339520?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2008-11. Estimated completion is 2010-05.

What interventions are being tested in trial NCT01339520?

The interventions under investigation include: Control (BEHAVIORAL), Scorecard (BEHAVIORAL).

Who is sponsoring clinical trial NCT01339520?

This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01339520's enrollment target sits among peer trials

104 836th of 2000 higher than 1,164 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01339520, the US trial registry maintained by the National Library of Medicine. NCT01339520 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.